MELAS
Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-like Episodes
mitochondrial inheritance
red-ragged fibers, hemiparesis, seizures
what illnesses do the following nucleoside analogs treat?
a. acyclovir
b. AZT
c. ddC
d. gemcitabine
e. remdesivir
a. acyclovir - HSV (deoxyguanosine)
b. AZT - HIV (thymidine)
c. ddC - HIV (deoxycytidine)
d. gemcitabine - cancer (deoxycytidine)
e. remdesivir - covid (adenosine)
function of quinolone drugs
block activity of DNA gyrase (prokaryotic Top II)
inhibit bacterial DNA synthesis
function of chemotherapeutic drugs Camptothecin and Adriamycin/Etoposide
Camptothecin targets Topo I
Adriamycin and Etoposide target Topo II
convert topoisomerases into DNA breaking agents by inhibiting ability of top to REJOIN DNA
what do inhibitors of HSV helicase-primase do?
stabilize interaction of helicase-primase with its viral DNA substrate
inhibiting progression of HSV DNA replication
(effective in HSV strains resistant to nucleoside-based therapies)
Dyskeratosis congenita
reduced telomerase activity —> affects stem and germ cells in tissues dividing rapidly/often
bone marrow failure due to loss of hematopoietic renewal
Lynch syndrome
HNPCC
mismatch repair (MMR) defect (shows MSI)
mutation in MSH2 or MLH1
colorectal cancer
mutation in DNA glycosylase MYH
high risk of colon cancer
defect in base excision repair (BER)
Werner’s syndrome
autosomal RECESSIVE
RecQ family WRN helicase mutation —> defect in BER
premature aging (20-30y), cataracts, atherosclerosis, cancer, telomere shortening
xeroderma pigmentosum (XP)
defect in GG-NER
XP protein mutations affecting recognition or helicase activity
solar sensitivity, skin cancer
cockayne syndrome
defective TC-NER
mutation in CSA or CSB recognition proteins
growth delays, intellectual disability, sun sensitive (but NOT cancer risk)
premature aging, from birth
Cisplatin
chemotherapeutic drug, forms bulky intra-strand adducts in DNA
treats tumors deficient in NER
ataxia oculomotor apraxia (AOA1)
autosomal RECESSIVE
mutation in aprataxin (APTX) - DNA “end processor” with hydrolase and transferase activity —> ssB repair defect
ataxia, oculomotor apraxia, hypercholesterolemia, hypoalbuminemia
ataxia telangiectasia (AT)
autosomal RECESSIVE
mutation in ATM (signal to cell cycle checkpoint, active in B/T development) —> dsB NHEJ defect
immune deficiency, chromosomal abnormalities (B, T cells), lymphoid cancer, hypersensitive to ionizing radiation
alpha-amanitin
mushroom toxin, inhibits RNA pol II
molnupiravir
covid drug (prodrug)
substrate for viral RNA-dependent RNA polymerase
causes viral mutagenesis, inhibiting viral replication
rifampicin
antibiotic specific for bacterial RNA pol
part of combination therapy for M. tuberculosis
Rett syndrome
X-linked DOMINANT** (heterogenous females only)
mutation in MECP2 (loss of methylation—> inappropriate gene expression)
begins young - seizures, lung infections, autism, failure to gain speech/walk
mis-regulation of transcription by HIV-1
programmed ribosomal frame shifting: generate >1 protein from single mRNA
pseudoknots stall ribosome
how does polio virus mess with translation
contains internal ribosome entry site (IERS) that allows cap-independent translation
cleaves eIF4G, diverts machinery, IRES binds eIF4G, direct recruitment of 40S
how does Corynebacterium diptheriae mess with translation
toxin (diphtheria) inactivates eEF-2 (transfers ADP-ribose from NAD), inhibiting translocation
presents with soar throat, grey/white pseudomembranes
hemochromatosis
autosomal RECESSIVE
defective iron storage (excess in body) - HFE mutation
phenotype varies by sex: women have mechanism to get rid of excess iron
most common single-gene inherited disease in US
male-limited precocious puberty
autosomal DOMINANT**
sex-limited, only expressed in males - early onset puberty
mutation in LH receptor (constitutively active)
females can carry but no phenotype
why does neurofibromatosis make creating a pedigree difficult
autosomal DOMINANT
but variable expressivity - all individuals affected, but severity varies